Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease

[1]  M. Hall.  National Heart, Lung, and Blood Institute , 2020, The Grants Register 2021.

[2]  E. Bleecker,et al.  Refractory airway type 2 inflammation in a large subgroup of asthmatic patients treated with inhaled corticosteroids , 2018, The Journal of allergy and clinical immunology.

[3]  P. O'Byrne,et al.  Expression of IL-33 and TSLP and Their Receptors in Asthmatic Airways after Inhaled Allergen Challenge. , 2018, American journal of respiratory and critical care medicine.

[4]  C. Auffray,et al.  Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: an exploratory analysis , 2018, European Respiratory Journal.

[5]  P. Busse,et al.  Asthma in the elderly and late‐onset adult asthma , 2018, Allergy.

[6]  P. Nair,et al.  Airway Inflammation and Inflammatory Biomarkers , 2018, Seminars in Respiratory and Critical Care Medicine.

[7]  J. Girard,et al.  Interleukin‐33 (IL‐33): A nuclear cytokine from the IL‐1 family , 2018, Immunological reviews.

[8]  E. Forno,et al.  Obesity and asthma , 2018, The Journal of allergy and clinical immunology.

[9]  Stacie M Jones,et al.  Individualized Therapy for Persistent Asthma in Young Children , 2017, Pediatrics.

[10]  M. Kool,et al.  Group 2 Innate Lymphoid Cells Exhibit a Dynamic Phenotype in Allergic Airway Inflammation , 2017, Front. Immunol..

[11]  S. Johnston,et al.  Viral infections in allergy and immunology: How allergic inflammation influences viral infections and illness , 2017, Journal of Allergy and Clinical Immunology.

[12]  P. O'Byrne,et al.  Allergen‐induced Increases in Sputum Levels of Group 2 Innate Lymphoid Cells in Subjects with Asthma , 2017, American journal of respiratory and critical care medicine.

[13]  M. Profita,et al.  Identification of IL‐17F/frequent exacerbator endotype in asthma , 2017, The Journal of allergy and clinical immunology.

[14]  S. Wenzel,et al.  Severe asthma in humans and mouse model suggests a CXCL10 signature underlies corticosteroid-resistant Th1 bias. , 2017, JCI insight.

[15]  W. Busse,et al.  Asthma Exacerbations: Pathogenesis, Prevention, and Treatment , 2017, The Journal of Allergy and Clinical Immunology: In Practice.

[16]  H. Nakajima,et al.  Allergic airway inflammation: key players beyond the Th2 cell pathway , 2017, Immunological reviews.

[17]  Frédéric Baribaud,et al.  U‐BIOPRED clinical adult asthma clusters linked to a subset of sputum omics , 2017, The Journal of allergy and clinical immunology.

[18]  C. Auffray,et al.  A Severe Asthma Disease Signature from Gene Expression Profiling of Peripheral Blood from U‐BIOPRED Cohorts , 2017, American journal of respiratory and critical care medicine.

[19]  M. D’Amato,et al.  Coexistence of obesity and asthma determines a distinct respiratory metabolic phenotype , 2017, The Journal of allergy and clinical immunology.

[20]  W. Calhoun,et al.  Biologic Therapy in Chronic Obstructive Pulmonary Disease. , 2017, Immunology and allergy clinics of North America.

[21]  Stacey N. Reinke,et al.  Metabolomics analysis identifies different metabotypes of asthma severity , 2017, European Respiratory Journal.

[22]  C. Auffray,et al.  A Transcriptome‐driven Analysis of Epithelial Brushings and Bronchial Biopsies to Define Asthma Phenotypes in U‐BIOPRED , 2017, American journal of respiratory and critical care medicine.

[23]  Dean P. Jones,et al.  High‐resolution metabolomics to identify urine biomarkers in corticosteroid‐resistant asthmatic children , 2017, The Journal of allergy and clinical immunology.

[24]  J. Fahy,et al.  Claudin‐18 deficiency is associated with airway epithelial barrier dysfunction and asthma , 2017, The Journal of allergy and clinical immunology.

[25]  K. Chung,et al.  Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study , 2016, Respiratory Research.

[26]  M. Cabana,et al.  Individualized therapy for persistent asthma in young children. , 2016, The Journal of allergy and clinical immunology.

[27]  S. Durham,et al.  Omalizumab reduces bronchial mucosal IgE and improves lung function in non-atopic asthma , 2016, European Respiratory Journal.

[28]  P. O'Byrne,et al.  Measuring Eosinophils to Make Treatment Decisions in Asthma. , 2016, Chest.

[29]  M. Kraft,et al.  Chronic Infection and Severe Asthma. , 2016, Immunology and allergy clinics of North America.

[30]  E. Bleecker,et al.  Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts. , 2016, The Lancet. Respiratory medicine.

[31]  Miguel Park,et al.  Diagnostic Utility of Urinary LTE4 in Asthma, Allergic Rhinitis, Chronic Rhinosinusitis, Nasal Polyps, and Aspirin Sensitivity. , 2016, The journal of allergy and clinical immunology. In practice.

[32]  E. Israel,et al.  Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease. , 2016, The Journal of allergy and clinical immunology.

[33]  Francisco Avila Cobos,et al.  Asthma inflammatory phenotypes show differential microRNA expression in sputum. , 2016, The Journal of allergy and clinical immunology.

[34]  C. Bachert,et al.  Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. , 2016, The Journal of allergy and clinical immunology.

[35]  Yusuke Nakamura,et al.  Dipeptidyl peptidase-4 is highly expressed in bronchial epithelial cells of untreated asthma and it increases cell proliferation along with fibronectin production in airway constitutive cells , 2016, Respiratory Research.

[36]  A. Bhandoola,et al.  Group 2 innate lymphoid cells mediate ozone-induced airway inflammation and hyperresponsiveness in mice. , 2016, The Journal of allergy and clinical immunology.

[37]  A. Moreira,et al.  Volatile organic compounds in asthma diagnosis: a systematic review and meta‐analysis , 2016, Allergy.

[38]  K. Samitas,et al.  Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives , 2015, European Respiratory Review.

[39]  Y. Kanaoka,et al.  Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene–Driven IL-33–Mediated Mast Cell Activation Pathway , 2015, The Journal of Immunology.

[40]  Ioannis Pandis,et al.  Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort , 2015, European Respiratory Journal.

[41]  D. Postma,et al.  Asthma , 2015, Nature Reviews Disease Primers.

[42]  S. Wenzel,et al.  High IFN-γ and low SLPI mark severe asthma in mice and humans. , 2015, The Journal of clinical investigation.

[43]  W. Paul,et al.  Innate Immune Function of TH2 Cells in vivo , 2015, Nature Immunology.

[44]  C. Sorkness,et al.  Markers of Differential Response to Inhaled Corticosteroid Treatment Among Children with Mild Persistent Asthma. , 2015, The journal of allergy and clinical immunology. In practice.

[45]  Airway Remodeling in Chronic Obstructive Pulmonary Disease and Asthma: the Role of Matrix Metalloproteinase-9 , 2015, Archivum Immunologiae et Therapiae Experimentalis.

[46]  C. Hall,et al.  Inflammation, metabolic dysregulation, and pulmonary function among obese urban adolescents with asthma. , 2015, American journal of respiratory and critical care medicine.

[47]  R. Lutter,et al.  External validation of blood eosinophils, FENO and serum periostin as surrogates for sputum eosinophils in asthma , 2014, Thorax.

[48]  W. Jefferies,et al.  The ion channel TRPV1 regulates the activation and proinflammatory properties of CD4+ T cells , 2014, Nature Immunology.

[49]  Ziv Bar-Joseph,et al.  Gene expression in relation to exhaled nitric oxide identifies novel asthma phenotypes with unique biomolecular pathways. , 2014, American journal of respiratory and critical care medicine.

[50]  Jonathan R. Brestoff,et al.  Basophils Promote Innate Lymphoid Cell Responses in Inflamed Skin , 2014, The Journal of Immunology.

[51]  Yongjian Xu,et al.  Epithelial interleukin-25 is a key mediator in Th2-high, corticosteroid-responsive asthma. , 2014, American journal of respiratory and critical care medicine.

[52]  J. Bousquet,et al.  Prevalence of asthma and its association with rhinitis in the elderly. , 2014, Respiratory medicine.

[53]  B. Undem,et al.  Mechanisms underlying the neuronal-based symptoms of allergy. , 2014, The Journal of allergy and clinical immunology.

[54]  Liang Dong,et al.  IL-33 promotes airway remodeling and is a marker of asthma disease severity , 2014, The Journal of asthma : official journal of the Association for the Care of Asthma.

[55]  J. Balmes,et al.  Outdoor air pollution and asthma , 2014, The Lancet.

[56]  T. Curtis,et al.  Increased expression of bronchial epithelial transient receptor potential vanilloid 1 channels in patients with severe asthma. , 2014, The Journal of allergy and clinical immunology.

[57]  P. Woodruff,et al.  Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma. , 2014, The Journal of allergy and clinical immunology.

[58]  D. Artis,et al.  Innate lymphoid cells and allergic inflammation. , 2013, Current opinion in immunology.

[59]  L. Rink,et al.  The Th17/Treg balance is disturbed during aging , 2013, Experimental Gerontology.

[60]  C. Persson.  Lysis of primed eosinophils in severe asthma. , 2013, The Journal of allergy and clinical immunology.

[61]  J. Marwick,et al.  Oxygen levels determine the ability of glucocorticoids to influence neutrophil survival in inflammatory environments , 2013, Journal of leukocyte biology.

[62]  S. Phipps,et al.  Elevated expression of the NLRP3 inflammasome in neutrophilic asthma , 2013, European Respiratory Journal.

[63]  J. Boyce,et al.  Lipid mediators and allergic diseases. , 2013, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[64]  E. Bleecker,et al.  Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects. , 2013, The Journal of allergy and clinical immunology.

[65]  Stacy L. Gelhaus,et al.  Prostaglandin D₂ pathway upregulation: relation to asthma severity, control, and TH2 inflammation. , 2013, The Journal of allergy and clinical immunology.

[66]  S. Wenzel,et al.  Asthma outcomes: biomarkers. , 2012, The Journal of allergy and clinical immunology.

[67]  S. Mosesova,et al.  Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. , 2011, The Journal of allergy and clinical immunology.

[68]  Lee， Jk,et al.  Lebrikizumab treatment in adults with asthma. , 2011 .

[69]  Nicola A Hanania,et al.  Lebrikizumab treatment in adults with asthma. , 2011, The New England journal of medicine.

[70]  W. Busse,et al.  What effect does asthma treatment have on airway remodeling? Current perspectives. , 2011, Journal of Allergy and Clinical Immunology.

[71]  E. von Mutius,et al.  Asthma-associated polymorphisms in 17q21 influence cord blood ORMDL3 and GSDMA gene expression and IL-17 secretion. , 2011, The Journal of allergy and clinical immunology.

[72]  W. Busse,et al.  Mast cell phenotype, location, and activation in severe asthma. Data from the Severe Asthma Research Program. , 2011, American journal of respiratory and critical care medicine.

[73]  J. Bernstein,et al.  A novel subset of CD4+ TH2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma , 2010, The Journal of experimental medicine.

[74]  Florence Demenais,et al.  A large-scale, consortium-based genomewide association study of asthma. , 2010, The New England journal of medicine.

[75]  G. Marks,et al.  Asthma in older adults , 2010, The Lancet.

[76]  Deborah A Meyers,et al.  Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes. , 2010, The Journal of allergy and clinical immunology.

[77]  E. A. Schwantes,et al.  Airway neutrophil inflammatory phenotype in older subjects with asthma. , 2010, The Journal of allergy and clinical immunology.

[78]  W. Paul.  What determines Th2 differentiation, in vitro and in vivo? , 2010, Immunology and cell biology.

[79]  D. Curran‐Everett,et al.  Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. , 2010, American journal of respiratory and critical care medicine.

[80]  Calman Prussin,et al.  IgE, mast cells, basophils, and eosinophils. , 2003, The Journal of allergy and clinical immunology.

[81]  Parameswaran Nair,et al.  Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. , 2009, The New England journal of medicine.

[82]  Qutayba Hamid,et al.  Increased Expression of IL-33 in Severe Asthma: Evidence of Expression by Airway Smooth Muscle Cells1 , 2009, The Journal of Immunology.

[83]  R. Vennekens,et al.  On the putative role of transient receptor potential cation channels in asthma , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[84]  Barmak Modrek,et al.  T-helper type 2-driven inflammation defines major subphenotypes of asthma. , 2009, American journal of respiratory and critical care medicine.

[85]  C. Lemière,et al.  T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. , 2009, The Journal of allergy and clinical immunology.

[86]  D. Metcalfe,et al.  The mast cell and allergic diseases: role in pathogenesis and implications for therapy , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[87]  D. Postma,et al.  Down-Regulation of E-Cadherin in Human Bronchial Epithelial Cells Leads to Epidermal Growth Factor Receptor-Dependent Th2 Cell-Promoting Activity1 , 2007, The Journal of Immunology.

[88]  H. Renz,et al.  Airway epithelial cells produce neurotrophins and promote the survival of eosinophils during allergic airway inflammation. , 2006, The Journal of allergy and clinical immunology.

[89]  D. Robinson,et al.  Thymic Stromal Lymphopoietin Expression Is Increased in Asthmatic Airways and Correlates with Expression of Th2-Attracting Chemokines and Disease Severity1 , 2005, The Journal of Immunology.

[90]  S. Wenzel,et al.  Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. , 2004, The Journal of allergy and clinical immunology.

[91]  J. Oliver,et al.  Immunohistochemical detection of human basophils in postmortem cases of fatal asthma. , 2001, American journal of respiratory and critical care medicine.

[92]  D. DeMets,et al.  Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.

[93]  K. Chung,et al.  Airway smooth muscle cells: contributing to and regulating airway mucosal inflammation? , 2000, The European respiratory journal.

[94]  M. Humbert,et al.  Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skin. , 2000, The Journal of allergy and clinical immunology.

[95]  S. Wenzel,et al.  Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. , 1999, American journal of respiratory and critical care medicine.

[96]  M. Brown,et al.  Cutting the cord: is birth already too late for primary prevention of allergy? , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[97]  P. Howarth,et al.  T-cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma. , 1996, American journal of respiratory cell and molecular biology.

[98]  M. Lebowitz,et al.  The relationship between parental and children's serum IgE and asthma. , 1995, American journal of respiratory and critical care medicine.